Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation

BACKGROUND: Review of clinical data on andexanet alfa for the reversal of factor Xa (FXa) inhibitor associated anticoagulation. DATA SOURCES: In the present review, we identified articles via PubMed using the combined keywords andexanet alfa, apixaban, enoxaparin, edoxaban, and rivaroxaban. Addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenter, Elise, Singh, Divita, Dietrich, Eric, Gums, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880028/
https://www.ncbi.nlm.nih.gov/pubmed/31807265
http://dx.doi.org/10.1177/2042098619888133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880028/
https://www.ncbi.nlm.nih.gov/pubmed/31807265
http://dx.doi.org/10.1177/2042098619888133

Ejemplares similares